Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunovant Inc. logo

Director Roivant Sciences Ltd. bought $349,999,986 worth of shares (16,666,666 units at $21.00), increasing direct ownership by 17% to 113,317,007 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMVT· Immunovant Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMVT (Immunovant Inc.) and more on Quantisnow.